These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35726220)

  • 1. Effect of CDCA5 on Proliferation and Metastasis of Triple Negative Breast Cancer Cells under shRNA Interference Technology.
    Li Y; Peng W; Deng Y; Heng J; Yang Y; Jin X; Li J; Li T
    J Oncol; 2022; 2022():9038230. PubMed ID: 35726220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Comprehensive Analysis Illustrates the Role of CDCA5 in Breast Cancer: An Effective Diagnosis and Prognosis Biomarker.
    Gao Y; Liu S; Yang J; Su M; Xu J; Wang H; Zhang J
    Int J Genomics; 2023; 2023():7150141. PubMed ID: 37287817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker.
    Shen Z; Yu X; Zheng Y; Lai X; Li J; Hong Y; Zhang H; Chen C; Su Z; Guo R
    Onco Targets Ther; 2018; 11():891-901. PubMed ID: 29503564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of CDCA5 Can Inhibit Cell Proliferation, Migration, and Invasion, and Induce Apoptosis of Prostate Cancer Cells.
    Chong Y; Xue L
    Crit Rev Eukaryot Gene Expr; 2021; 31(1):29-40. PubMed ID: 33639053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell division cycle associated 5 promotes colorectal cancer progression by activating the ERK signaling pathway.
    Shen A; Liu L; Chen H; Qi F; Huang Y; Lin J; Sferra TJ; Sankararaman S; Wei L; Chu J; Chen Y; Peng J
    Oncogenesis; 2019 Feb; 8(3):19. PubMed ID: 30808873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of nucleophosmin 1 suppresses proliferation of triple-negative breast cancer cells through activating CDH1/Skp2/p27kip1 pathway.
    Zeng D; Xiao Y; Zhu J; Peng C; Liang W; Lin H
    Cancer Manag Res; 2019; 11():143-156. PubMed ID: 30613163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDCA5 functions as a tumor promoter in bladder cancer by dysregulating mitochondria-mediated apoptosis, cell cycle regulation and PI3k/AKT/mTOR pathway activation.
    Fu G; Xu Z; Chen X; Pan H; Wang Y; Jin B
    J Cancer; 2020; 11(9):2408-2420. PubMed ID: 32201512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer.
    Kariri YA; Joseph C; Alsaleem MA; Elsharawy KA; Alsaeed S; Toss MS; Mongan NP; Green AR; Rakha EA
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of cell division cycle‑associated 5 promotes cell apoptosis by activating DNA damage response in clear cell renal cell carcinoma.
    Huang X; Huang Y; Lv Z; Wang T; Feng H; Wang H; Du S; Wu S; Shen D; Wang C; Li H; Wang B; Ma X; Zhang X
    Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35642672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Cdc20 suppresses the metastasis in triple negative breast cancer (TNBC).
    Song C; Lowe VJ; Lee S
    Breast Cancer; 2021 Sep; 28(5):1073-1086. PubMed ID: 33813687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
    Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K
    Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC).
    Tian Y; Wu J; Chagas C; Du Y; Lyu H; He Y; Qi S; Peng Y; Hu J
    BMC Cancer; 2018 Nov; 18(1):1187. PubMed ID: 30497429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Multi-omics Analyses Identify CDCA5 as a Novel Biomarker Associated with Alternative Splicing, Tumor Microenvironment, and Cell Proliferation in Colon Cancer Via Pan-cancer Analysis.
    Bao X; Leng X; Yu T; Zhu J; Zhao Y; Tenzindrogar ; Yang Z; Wu S; Sun Q
    J Cancer; 2024; 15(3):825-840. PubMed ID: 38213717
    [No Abstract]   [Full Text] [Related]  

  • 14. Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT.
    Zhu Y; Tao Z; Chen Y; Lin S; Zhu M; Ji W; Liu X; Li T; Hu X
    Breast Cancer Res Treat; 2022 May; 193(1):65-81. PubMed ID: 35254603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of targeting cell division cycle associated 5 for oral squamous cell carcinoma.
    Tokuzen N; Nakashiro K; Tanaka H; Iwamoto K; Hamakawa H
    Oncotarget; 2016 Jan; 7(3):2343-53. PubMed ID: 26497678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-Dependent Kinase 1 (CDK1) is Co-Expressed with CDCA5: Their Functions in Gastric Cancer Cell Line MGC-803.
    Huang Z; Zhang S; Du J; Zhang X; Zhang W; Huang Z; Ouyang P
    Med Sci Monit; 2020 Aug; 26():e923664. PubMed ID: 32759885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of down-regulation of Oct4 gene on biological characteristics of MDA-MB-231 breast cancer stem cells].
    Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):251-7. PubMed ID: 26462888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation and activation of cell division cycle associated 5 by mitogen-activated protein kinase play a crucial role in human lung carcinogenesis.
    Nguyen MH; Koinuma J; Ueda K; Ito T; Tsuchiya E; Nakamura Y; Daigo Y
    Cancer Res; 2010 Jul; 70(13):5337-47. PubMed ID: 20551060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.
    Liu H; Wang Y; Li X; Zhang YJ; Li J; Zheng YQ; Liu M; Song X; Li XR
    Tumour Biol; 2013 Jun; 34(3):1713-22. PubMed ID: 23430586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation.
    Al-Marsoummi S; Vomhof-DeKrey E; Basson MD
    Cell Physiol Biochem; 2019; 53(6):999-1014. PubMed ID: 31838790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.